[Hopespringpcsg] FW: Opportunity to participate in a survey about a survey on Xtandi!
Glen Tolhurst
glen46nor at gmail.com
Wed Sep 24 20:10:12 EDT 2014
See survey below.
Subject: Opportunity to participate in a survey about a survey on Xtandi!
Hello all,
Please take a few moments of your time to participate in our survey about Xtandi and/or send it to friends, colleagues or fellow support group members.
The purpose of this survey is to provide the us with insights and perspectives about living with and managing metastatic prostate cancer from patients and caregivers in order to complete a patient evidence submission to the pan-Canadian Oncology Drug Review for enzalutamide (Xtandi) for the treatment of patients with metastatic castration-resistant prostate cancer (mPRPC) who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy who have not received prior chemotherapy.
This survey will be available starting now and remain open until October 6, 5 pm, 2014.
To access the survey, go to https://www.surveymonkey.com/s/JCXNYJH
Thank you for your participation!
Best,
Jackie
--
Jackie Manthorne
President and CEO
Présidente et chef de la direction
Canadian Cancer Survivor Network
Réseau canadien des survivants du cancer
1750 croissant Courtwood Crescent, Suite 210
Otttawa, ON K2C 2B5
Telephone / Téléphone : 613-898-1871
E-mail / Courriel : jmanthorne at survivornet.ca
Web site / site web: www.survivornet.ca
Blog: http://jackiemanthornescancerblog.blogspot.com/
Twitter: @survivornet.ca
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://artsservices.uwaterloo.ca/pipermail/hopespringpcsg/attachments/20140924/fa5e24ab/attachment.html>
More information about the Hopespringpcsg
mailing list